EUVIMEDSkopri EUVIMED
Open access · CC BY-NC 4.0

Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA‐dependent RNA polymerase using molecular modeling approach

Mansi Dutt, Anuj Kumar iD, Madhusmita Rout, Budheswar Dehury iD, Gustavo Martinez, Pacifique Ndishimye, Alyson A Kelvin, David J Kelvin

Journal of Cellular Biochemistry · 2023

DOI: 10.1002/jcb.30397 ↗

At a glance

Journal article in Journal of Cellular Biochemistry, 2023. Written by Mansi Dutt and 7 co-authors. Institution: Department of Microbiology and Immunology, Department of Paediatrics, IWK Health Center, Canadian Centre for Vaccinology (CCfV), Faculty of Medicine,…. Major MEDLINE topics: Drug Repositioning, Mpox, Monkeypox. Cited 33 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: CIHR, Dalhousie Medical Research Foundation, Li Ka Shing Foundation.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Mpox (formerly Monkeypox), a zoonotic illness caused by the Mpox virus, belongs to the Orthopoxvirus genus in the family Poxviridae. To design and develop effective antiviral therapeutics against DNA viruses, the DNA‐dependent RNA polymerase (DdRp) of poxviruses has emerged as a promising drug target. In the present study, we modeled the three‐dimensional (3D) structure of DdRp using a template‐based homology approach. After modeling, virtual screening was performed to probe the molecular interactions between 1755 Food and Drug Administration‐approved small molecule drugs (≤500 molecular weight) and the DdRp of Mpox. Based on the binding affinity and molecular interaction patterns, five drugs, lumacaftor (−11.7 kcal/mol), conivaptan (−11.7 kcal/mol), betulinic acid (−11.6 kcal/mol), fluspirilene (−11.3 kcal/mol), and imatinib (−11.2 kcal/mol), have been ranked as the top drug compounds interacting with Mpox DdRp. Complexes of these shortlisted drugs with DdRp were further evaluated using state‐of‐the‐art all‐atoms molecular dynamics (MD) simulations on 200 nanoseconds followed by principal component analysis (PCA). MD simulations and PCA results revealed highly stable interactions of these small drugs with DdRp. After due validation in wet‐lab using available in vitro and in vivo experiments, these repurposed drugs can be further utilized for the treatment of contagious Mpox virus. The outcome of this study may establish a solid foundation to screen repurposed and natural compounds as potential antiviral therapeutics against different highly pathogenic viruses.

Subjects

MeSH terms (MEDLINE)

Drug RepositioningMpox, MonkeypoxHumansDNA-Directed RNA PolymerasesMolecular Dynamics SimulationAntiviral AgentsMolecular Docking Simulation

Author keywords

DNA-dependent RNA polymerase (DdRp)Mpox virushomology modelingmolecular dynamics simulationssmall moleculesvirtual screening

Substances

DNA-Directed RNA PolymerasesAntiviral Agents

Authors and institutions

  • Department of Microbiology and Immunology, Department of Paediatrics, IWK Health Center, Canadian Centre for Vaccinology (CCfV), Faculty of Medicine, Dalhousie University, Halifax, Canada.
  • European Virus Bioinformatics Center, Jena, Germany.
  • Bioinformatics Division, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

ORCID profiles: Anuj Kumar, Budheswar Dehury

Funding

  • CIHR
  • Dalhousie Medical Research Foundation
  • Li Ka Shing Foundation
  • Canadian Institutes of Health Research

Cite

APA

Dutt, M., Kumar, A., Rout, M., Dehury, B., Martinez, G., Ndishimye, P., Kelvin, A. A., & Kelvin, D. J. (2023). Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA‐dependent RNA polymerase using molecular modeling approach. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30397

Vancouver

Dutt M, Kumar A, Rout M, Dehury B, Martinez G, Ndishimye P, et al. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA‐dependent RNA polymerase using molecular modeling approach. Journal of Cellular Biochemistry. 2023. doi:10.1002/jcb.30397

BibTeX
@article{Dutt2023,
  author = {Dutt, Mansi and Kumar, Anuj and Rout, Madhusmita and Dehury, Budheswar and Martinez, Gustavo and Ndishimye, Pacifique and Kelvin, Alyson A and Kelvin, David J},
  title = {Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA‐dependent RNA polymerase using molecular modeling approach},
  journal = {Journal of Cellular Biochemistry},
  year = {2023},
  doi = {10.1002/jcb.30397}
}
Start for free →